Xenon Pharmaceuticals Inc. (XENE)
$36.44+0.77%Close
SELLCRISIS · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.5B
- Beta
- 0.60
- P/E (TTM)
- -7.72
- Short % float
- 6.66%
- Days to cover
- 1.6
- SI change
- -6.3%
- 1W
- -4.16%
- 1M
- -38.03%
- vs SPY 1W
- -5.32%
- vs SPY 1M
- -41.02%
Industry peers
FMP comparable companies · ranked by market cap
- NBIXSELLNeurocrine Biosciences, Inc.$14.6BRECOVERYQ 17$145.51+0.84%
- JAZZSELLJazz Pharmaceuticals plc$14.5BBEARQ 24$231.39-1.81%
- AXSMSELLAxsome Therapeutics, Inc.$9.0BCRISISQ 34$174.34-1.02%
- PRAXSELLPraxis Precision Medicines, Inc.$7.8BCRISISQ 11$280.14-1.40%
- ACADSELLAcadia Pharmaceuticals Inc.$3.4BCRISISQ 18$19.74+1.02%
- DNLISELLDenali Therapeutics Inc.$3.1BCRISISQ 8$19.28+4.18%
- SUPNBUYSupernus Pharmaceuticals, Inc.$2.5BRECOVERYQ 26$42.83+1.26%
- RAPPSELLRapport Therapeutics, Inc. Common Stock$1.5BCRISISQ 26$31.15+2.68%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
